- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05687370
Modified Dynamic Needle Tip Positioning vs Conventional Long-axis In-plane in Radial Artery Cannulation
March 28, 2023 updated by: Meng Lv, Qianfoshan Hospital
Modified Dynamic Needle Tip Positioning Versus Long-Axis In-Plane Ultrasound Guided Radial Artery Cannulation in Patients With Coronary Artery Disease: A Randomized Controlled Trial
Conventionally, long-axis in-plane (LA-IP), short-axis out-of-plane (SA-OOP) and dynamic needle tip positioning based on SA-OOP views are commonly used method to image the target vessel during cannulation under US guidance.
A modified SA-OOP that add developing line on the ultrasonic probe improve the success rate of cannula insertion into the radial artery on the first attempt.
Study Overview
Status
Completed
Study Type
Interventional
Enrollment (Actual)
124
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shandong
-
Jinan, Shandong, China, 250014
- Shandong Provincial Qianfoshan Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- The diagnostic criteria of coronary atherosclerotic heart disease according to the tenth version of international Classification of diseases(ICD-10);
- Requires invasive arterial blood pressure monitoring;
- New York Heart Association(NYHA) classification I, II or III;
- The American Society of Anesthesiologists (ASA) classification I, II or III;
- Patients older than 18 years and younger than 85 years (Adult);
- Patients signed the informed consent before the study.
Exclusion Criteria:
- Patients with hemodynamically unstable (systolic blood pressure 60 or less);
- Patients with abnormal results of the modified Allen test;
- Patients with ulnar artery occlusion;
- Patients with coagulation disorders;
- Patients with skin abnormalities such as inflammation or hematoma at the cannulation site;
- Patients with raynaud disease and prevalent atherosclerosis;
- Patients with history of hand or wrist trauma or surgery;
- Patients who have undergone radial artery interventional therapy or radial artery cannulation within 3 months on the puncture side;
- Patients with BMI more than 40 kg/m2;
- Patients who have participated in other relevant clinical studies within 3 months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Modified dynamic needle tip positioning technique
In Modified dynamic needle tip positioning technique, short-axis in-plane is used, needle tip was dynamic guided by ultrasound that added two developing lines on the ultrasonic probe.
|
The tip of needle is positioned under ultrasound-guidance using modified dynamic short-axis view.
|
Active Comparator: Long-axis in-plane technique
|
The tip of needle is positioned under ultrasound-guidance using conventional long-axis in-plane view.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Success rate of the radial artery cannulation at first attempt
Time Frame: intraoperative
|
Successful confirmation of the arterial waveform through a pressure monitor at first attempt of the radial artery cannulation
|
intraoperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time of arterial catheterization
Time Frame: Interval between contact of the ultrasound transducer with the skin and confirmation of an arterial waveform on the monitor, an expected average observation time of 300 seconds
|
Interval between contact of the ultrasound transducer with the skin and confirmation of an arterial waveform on the monitor, an expected average observation time of 300 seconds
|
|
Time to first puncture of the artery
Time Frame: Interval between skin penetration of the needle and flashback of blood, an expected average of 200 seconds
|
Interval between skin penetration of the needle and flashback of blood, an expected average of 200 seconds
|
|
Time ultrasound imaging
Time Frame: Interval between contact of the ultrasound transducer with the skin and penetration of the needle through the skin, , an expected average of 100 seconds
|
Interval between contact of the ultrasound transducer with the skin and penetration of the needle through the skin, , an expected average of 100 seconds
|
|
Number of puncture attempts
Time Frame: Up to 5 times, an expected average observation time of 70 seconds
|
Up to 5 times, an expected average observation time of 70 seconds
|
|
Vascular complications in the surgery
Time Frame: postoperative, within 24 hours
|
including thrombosis, hematoma, and vasospasm
|
postoperative, within 24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Meng Lv, doctor, Jinan, Shandong Province, China, 250000
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 15, 2023
Primary Completion (Actual)
March 26, 2023
Study Completion (Actual)
March 26, 2023
Study Registration Dates
First Submitted
December 4, 2022
First Submitted That Met QC Criteria
January 16, 2023
First Posted (Actual)
January 18, 2023
Study Record Updates
Last Update Posted (Actual)
March 30, 2023
Last Update Submitted That Met QC Criteria
March 28, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- YXLL-KY-2022(104)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
China National Center for Cardiovascular DiseasesRecruitingLeft Main Coronary Artery DiseaseChina
Clinical Trials on Modified dynamic needle tip positioning under ultrasound-guidance
-
Seoul National University HospitalSMG-SNU Boramae Medical CenterCompletedUltrasonography | Central Venous Catheterization | Cardiac Surgical ProceduresKorea, Republic of
-
Seoul National University HospitalCompletedUltrasonography | Cardiac Surgical Procedures | CatheterizationKorea, Republic of
-
Guangdong Provincial Hospital of Traditional Chinese...Health and Family Planning Commission of GuangdongActive, not recruitingPercutaneous Coronary Intervention | Distal Radial Artery | Ultrasonography, Doppler | Coronary ArteriographyChina
-
University Hospital, LinkoepingCompletedEmergencies | Overweight and ObesitySweden
-
Rabin Medical CenterUnknownPeripheral Venous Cannulation
-
Mahidol UniversityRecruitingPain, Postoperative | Breast Cancer FemaleThailand